michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So Paul, couple things, one, we had, as you remember, it took us a while to get to a cash generating position in Life Sciences, and we've been there for better part of almost 2 years, the size is pretty significant and the amount of investment that we need to make to stay in front of the opportunity we think those are short cycle decisions. We're pretty aggressive about expanding capacity and capability and the team has really demonstrated that they are able to capture everything that we invest in, so that's been pretty significant.
At the same time, we have a semi business that has its own trajectory and its own investment patterns. And when we looked at it, we looked at the balanced opportunity here to stand up to companies and make sure they didn't compete for capital. We think it will keep them both on really significant growth path. And if anything allow them to both accelerate by having -- by not sharing the balance sheet actually, but each having their own independent balance sheet. So size, scale and overall capability of a Life Sciences business that's now running at $500 million run rate we think made this a really right time for us to stay in the business.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. And I think one of the things that we talked about is, we're going to be very choiceful about how we deploy our media and which is the effect of the marketing spend that we're incurring. And I think we're just [Indecipherable] look at what is happening actually with the pandemic and the pandemic trajectory. So depending on when things become much more clear in terms of pent-up demand being leveraged in a much more significant way, we've historically done a lot of advertising and marketing around the time we actually sell our passes, and so that that typically has been done spring and fall. But I think in this year, we could look at it as spring, summer and fall and we will time our spend to make sure we are driving that demand and accelerate it.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. It's a great question and it's a pretty simple answer. Historically, we do not normally deliver the price per home in the backlog because the more expensive houses take longer to build. So, as you saw, the fourth quarter's sales price breakthrough $1 million, those more expensive homes are bigger, they're more complicated, they have more upgrades and options and they just take a bit longer to build. So there is a lag on the upper end of the sales price. And I think that is the answer. The faster turn comes from the affordable luxury and the less expensive homes. And so, while we're really proud of the price increases that are coming in the future of revenue, that's the reason why it doesn't perfectly match what you see in our more recent sales and on our year-end backlog.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Paul. Just want to thank everyone for joining us today. We're obviously pleased with our results and even more pleased to welcome our new colleagues from Boston Private to SVB. Private banking and wealth management is obviously a critical area of focus for us. One of the four key pillars of our strategy along with commercial banking, investment banking and SVB Capital. And we certainly believe that what you're going to hear more and more about on a quarterly basis is how we pull all four of these pillars together to build an incredible story for our clients.
We're focused on strong execution to being the best partner possible to our clients, while doing the right thing for our employees. And that really informs how we're approaching our return to office and the future of work at SVB with thinking about our client, our employees and making sure they're safe and taking care of them. So we're doing return to office trials right now, and the future work at SVB is going to be one that is going to be flexible.
We've listened to our employees, we've listened to our clients and we believe that a flexible work environment is going to be the best thing for them and the best for our clients and quite honestly be a competitive advantage for us. As always, I want to call out and thank our incredible team. I'm so proud of what they've done, how they've done it, doing it virtually for the last 18 months and it looks like a few more months to go, and for our amazing clients for giving us a great reason to come to work every day albeit virtually. Thanks a lot, and have a great day.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, there will be meaningful cost savings from combining into one platform. I think there also will be meaningful consumer benefits from combining into one platform. And I think the other thing to keep in mind is, yes, part of what in David's comments about us being more disciplined and tactical at this stage of phasing the further roll-outs of Discovery+, for example, is also a view toward we may be able to more quickly in markets where we may not have launched discovery+ to be able to more quickly fold the content offering into a joint platform at that stage versus having to replatform two existing platforms in a market into one.
And so, I think speed to market will be a variant of both where we have and haven't launched, number one. And number two, while the final decisions on exactly which parts of the tech platform we migrate to will influence how long it takes us to get there, but remember that there may be two phases to this, where there may be an initial phase which allows for more of a quick bundling of services, and a second phase which eventually allows for, obviously, a common service on one tech platform. That's a timeline and evolution certainly, Jess, that we'll talk to you more in detail as soon as we can give you more color.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, good morning, everyone. Hey, just one question here. Scott, the comment that you made, and Ted, you can chime in on this. Just the comment about being among the best margin producers in the business while remaining the low-cost leader when the recovery has fully taken hold.
I'm just -- I'm taking that from the release. When I sort of think about your model, at least historically, let's move the September quarter aside because of the irregular operations, I mean that was just extreme. But when I think about your model historically, you would be the best margin producer and also among the low-cost leaders as we went through downturns. That's usually when the ULCC, LCC model really thrived and you would outperform.
And it just feels like based on this statement here that maybe things have changed a bit. And maybe it's that this labor inflation is going to be with us a little bit longer. And I realize that historically, for the ULCCs, LCCs, labor has been maybe a larger area from a cost advantage perspective vis-a-vis the big carriers and the legacies. So I'm just -- I'm curious if there's kind of a shift in philosophy here or maybe you're just sort of hedging your bets, maybe being conservative, maybe this downturn that we went through is like no other, and we can't really comp it against the GFC or 9/11.
I mean just your thoughts on that. Thank you.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Thanks for the question, Sterling. Regarding the overall on -- across Apple devices, whether it be a Mac, iPad, iPhone, even Apple TVs, we're growing across the board. And definitely, the emergence of the new Mac is we see as increasing demand for the Mac that's out there.
But our fastest-growing apps or devices by count are iOS devices, iPhone and iPads. And that is largely driven, we believe, not only, of course, by the demand of those devices. But because of our strong presence in the Mac out there in commercial markets, especially, customers already have great experience with us. And they see the benefit of being able to run all of their Apple devices into one system.
So the strength of what we have on the Mac is actually creating much of the growth we're seeing on the iOS side.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So as I mentioned in my prepared remarks, we are investing a lot in opening new sites globally also because of the penetration to new customers in several areas, including in Europe, in China and other areas. So as a result of that, some of the expenses are related to the service organization and the spread of our field service engineers globally. On top of that, obviously, there are pressure from the supply chain in terms of cost of materials, deliveries, and this is obviously building up quarter-over-quarter. On top of that, we had, in the third quarter, as I mentioned, record revenues from software. This is probably going to normalize a little bit in the fourth quarter. And all these elements together have some impact on the gross margins.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, I expect we'll share the data after the placebo-controlled phase because that first part of the study is very important in terms of establishing the PK/PD relationship in Huntington disease patients. That will be very important and formally the dose level for the efficacy trial, whether that's done as a Phase three or we're able to take advantage of the accelerated approval pathway as opposed to marketing. So we do believe that datasets our employees would share.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
But I think the other aspect of your question, you're going to have to remind again now. I got lost the track of it.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
That's right, That's right. And so...

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Welcome Justin as well.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, because an ever-growing portion of Protiviti is this blended activity with staffing. We frankly think it's best to look at our enterprise margins rather than staffing alone or Protiviti alone. And all the comments I just made apply to the enterprise.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We did know that our production and costs are both expected to increase throughout the year. So higher in the second half than the first half. And on the cost side, that's related to increased operating lease stripping in the second half. And on the production side, I think it's mostly [Inaudible] that's increasing in the second half.
On capex, it's fairly consistent throughout the year, but we do tend to -- we do historically tend to spend more in the second half. But at the start of the year, it does look like fairly even throughout the year.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, so the gross margins, if we're talking consolidated staffing gross margins, which include tip contract and perm, we're actually higher than that. And so we're not below historical gross margins. So, let's look, first of all, at temp and contract only we were at but 39.7% this quarter that's the highest ever. Permanent placement margins are pretty much in line with what they've always been. The mix of perm to the total is higher than it's ever been. So, when you put the two together, we have the highest staffing consolidated, gross margins in our history. And as I just said, we think we have upside from here, primarily as we continue up the skill curve and higher skills are our friend from a margin standpoint. So, today we have our highest gross margins ever, and we think we have upside as we continue to move up the skill mix.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. I think I would say my outlook is pretty optimistic. I'll talk about the Texas thing first. Our payments business, or the NIC payments business in Texas is one of our strong outperformers this quarter. When you talk about -- we mentioned Utah, and we mentioned Oklahoma, these were early renewals.
And part of that -- actually, the reason for the early renewal was some of the excitement that's been generated through NIC with the customer about what the combined entity of Tyler, NIC can bring. We've talked about our connected communities vision. We've talked about the different products and offerings that we can bring. And I think both of these states were areas where they're seeing that future and they wanted to go ahead and jump in early, which gives me optimism for what I think we'll see going forward in the market.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Michael, why don't you start? And then we can provide some additional color as Christina talked about our inventory positions.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, thanks for taking my questions. First question on B7-H3. How does your CD28 approach and program compared to other B7H3 approaches and programs and development?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, Jeff, certainly we do note and expect some longer than normal lead times in the near-term that's near-term and as you indicated in particular, the core equipment category. We do view this as a near-term issue and certainly working closely with our manufacturer partners to minimize the disruption and keep our customers informed. But it should also be noted that our funnel is strong and the situation that we're dealing with here in the near-term is not only related to supply chain issues, but also due to the strong demand for these products. So I think that's an important point to note as well.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So, I think it's -- I think the definition is pretty standard in terms of patients being elderly, obese, diabetic, immunosuppressed. And I think also, potentially, asthmatic patients with underlying renal disease, underlying tumors, and so forth.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, Mike, it's Andy. We're spending a lot of time in that internally. And I'll tell you what, we're going to put something in the earnings release and deck by the end of the year to give you more information on this. We are looking at it on a regular basis. It's one of our top priorities. I think it's a huge opportunity both from an increased penetration to current customers as well as customer acquisition and we'll give you more on this before the end of the year.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, Luisa. I think we have already shared as much as we can on -- based on the visibility that we have today on the -- during the presentation. So once again looking forward to 2021, you can use the answer that I have given for Life Science such as proxy, right, because our Healthcare will move on the high efficacy dynamic market progression, as Peter repeatedly said, and also the increased mobility that is actually reflected already during our Q1 results associated and implicating Fertility and other businesses. So as vaccination progress, we cannot expect anything, but better mobility and recovery presuming the traditional healthcare dynamics of the past spending and this is a different question and it's not related to mobility the high efficacy dynamic market trend.
On Life Science, I mentioned that already, we have an ongoing multi-year program to expand our Life Science capacity to support this global and growing demand and so far we are really on track. I mentioned how heavily we have invested in the last months and that amounted to EUR350 million. And is because we believe that the trend will continue as you see each and every vaccine manufacturers have announced new commitments, speaking of new base in doses being produced and committed to different countries and governments and as we see this trend be kept to the future. This is giving us confidence that we are going to be a farther developing the business mainly in Life Science on the basis of our increased capacity and that is really the main element that could make a difference between the low and high part of the range on revenues, obviously.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. There are no tax consequences in the company.

    Prediction (one of UP, DOWN, SAME): DOWN